Project A and Oakley Capital invest in WindStar Medical, a top OTC consumer healthcare company in Germany, to support its growth in e-commerce and direct-to-consumer markets.
Target Information
WindStar Medical is a prominent over-the-counter (OTC) consumer healthcare company located in Germany. The organization specializes in the development and distribution of high-quality health products and brands through various channels, including drugstores, supermarkets, and online platforms. WindStar Medical has experienced exceptional growth, increasing its revenue from EUR 70 million in 2016 to nearly EUR 130 million in 2020. The company's extensive portfolio features well-known brands such as SOS (wound care and disinfectants), Zirkulin (gastro-intestinal care), GreenDoc (mental well-being), and EyeMedica (eye health).
Under the leadership of CEO René Flaschker, WindStar Medical has continually reinvented itself since its inception, emphasizing innovation and responsiveness to the evolving healthcare market. With a strategic focus on expanding its online direct-to-consumer (D2C) and e-commerce presence, the company aims to adapt to the digital transformation reshaping the industry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The consumer healthcare market in Germany is experiencing robust growth, driven by increasing awareness of health and wellness among consumers. The shift towards self-medication and the rising demand for OTC products are encouraging pharmaceuti
Similar Deals
Q·CAPITAL VENTURES → fresh five* premiumfood Ltd.
2023
QC·VENTURES → fresh five* premiumfood GmbH
2023
European Circular Bioeconomy Fund → Prolupin
2023
Odewald KMU → Karl Schmidt GmbH
2023
Project A
invested in
WindStar Medical
in 2020
in a Growth Equity & Expansion Capital deal
Disclosed details
Revenue: $130M